Ireland
--:--IST
Latest
Clinical Trials in Taiwan / NCT07509619
Recruiting Observational

AI-based Physiotherapy Evaluation System for Range of Motion in Oral Cancer Patients

NCT07509619 · tracked via the Priya Life Science Taiwan tracker
Phase
Observational
Started
2026-04-07
Last updated
2026-04-13

Condition(s) studied

Oral CancerAI (Artificial Intelligence)

Study summary

This study aims to evaluate the validity and reliability of a novel AI-based physiotherapy evaluation system for measuring oromandibular and neck-shoulder range of motion (ROM). Traditional ROM assessments rely on manual measurements, which may be influenced by rater experience and variability. The proposed AI system uses automated keypoint tracking to provide objective and standardized measurements.

In this cross-sectional study, healthy adult participants will perform standardized ROM tasks. Measurements obtained from the AI system will be compared with those from two independent raters using conventional clinical tools. Repeated measurements will be conducted to assess intra-rater and inter-rater reliability. The agreement between the AI system and human raters will be evaluated to determine the system's clinical applicability.

Eligibility

Sex
ALL
Min age
20 Years
Max age
70 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy adults aged 20 to 70 years * No trismus * No history of head, neck, or shoulder injury or surgery * No history of head and neck cancer-related radiotherapy or chemotherapy Exclusion Criteria: * Inability to communicate or follow instructions * Any condition that may affect movement performance

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University Taipei Taiwan Recruiting

More National Taiwan University Hospital trials in Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07509619 on ClinicalTrials.gov ↗ ← All trials in Taiwan